Scalable revenue cycle ecosystem designed to support anticipated billing volumes; CNSide assay billing to begin in Q3 2026 with accumulated 2026 backlog of tests and concurrent case billing
Latest News
Featured News
Medical Devices and Biotechnology News
Scalable revenue cycle ecosystem designed to support anticipated billing volumes; CNSide assay billing to begin in Q3 2026 with accumulated 2026 backlog of tests and concurrent case billing
Analyzes 100% of patient interactions to remove barriers to patient access, reduce cost, capture revenue growth, improve the patient experience, and drive measurable EBITDA gains
Teleflex Medical OEM Launches as INGENYX to Empower Tomorrow’s MedTech Innovators
Combining leading in-house expertise with platform-enhancing investments to accelerate advances in engineering, innovation and manufacturing capabilities serving global medical device innovators
Effective August 1, 2026, the agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for BRIJ-SEAL™, joining BRIJ Medical's existing Premier Breakthrough Technology designations for Brijjit® BP-100 and Brijjit® BP-75 Force Modulating Tissue Bridges
Caris Precision Oncology Alliance Welcomes the University of New Mexico Comprehensive Cancer Center
Partnership expands collaborative research network dedicated to advancing precision medicine and improving outcomes for cancer patients
The marketing authorization is valid in all 27 European Union (“EU”) Member States, as well as Iceland, Liechtenstein and Norway. Pfizer and BioNTech have already initiated manufacturing of the monovalent XFG-adapted COVID-19 vaccine at risk to ensure supply readiness in anticipation of the respiratory disease season, when the demand for COVID-19 vaccination is expected to increase.
Clinical Trials | Funding | Mergers & Acquisitions | Market Reports
Initiation of study marks an important milestone in advancing Neurocrine's obesity portfolio and investigational metabolic disease pipeline
P&F Products & Features GmbH Announces Acquisition of AVVie GmbH
The acquisition strengthens P&F's structural heart portfolio with the addition of the AngelValve™ Augmentation System, a novel transcatheter solution for mitral regurgitation, further expanding the company's portfolio of next-generation transcatheter heart valve therapies and reinforcing its long-term commitment to structural heart innovation
To Accelerate Global Expansion of AI-Powered Intraoperative Imaging
Jascayd: EU approval marks new chapter in pulmonary fibrosis, says GlobalData
Jascayd is a first-in-class phosphodiesterase 4B (PDE4B) inhibitor that has been designed to have isoform selectivity to retain the antifibrotic and anti-inflammatory effects of PDE4 inhibition while avoiding the tolerability constraints that have limited previous nonselective PDE4 inhibitors in respiratory diseases
Adventist Health Glendale is the first site able to enroll patients in the ChoICE Study after signing both an agreement and receiving IRB approval
BayCare Among First in Florida to Offer Next-Generation Breast Surgery Procedure
As BayCare continues to advance breast cancer care, robotic-assisted nipple-sparing mastectomy offers eligible patients another innovative option tailored to their medical and personal needs
New collaborations expand wearable and out-of-hospital monitoring capabilities, helping support continuous patient visibility from admission through recovery at home
Rongtao Medical Wins Bonded Repair Approval as One of the First in China for Ultrasound
Approval eliminates import duties, VAT, and temporary-import deposits on cross-border ultrasound repair shipments to Rongtao Medical's global repair headquarters in the Guangzhou Huangpu Comprehensive Bonded Zone
The American Foundation for Suicide Prevention (AFSP) applauds Congress for passing the bipartisan Youth Poisoning Protection Act, marking a significant milestone in a years-long effort to prevent suicide by reducing access to a highly lethal means
Participation in the FasterCures TRAIN network strengthens DDF's ability to connect researchers with the resources and relationships that accelerate stomach cancer research.
